Prosecution Insights
Last updated: April 19, 2026

Mthera Pharma Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18038524 COMPOSITION FOR PREVENTING, IMPROVING OR TREATING INFLAMMATORY BOWEL DISEASE, COMPRISING ISATIDIS FOLIUM EXTRACT BOECKELMAN, JACOB A 1655 Final Rejection May 24, 2023
17767604 Composition For Preventing Or Treating Neurodegenerative Diseases Containing Mixed Herbal Extract Of Genkwae Flos, Clematidis Radix, And Gastrodiae Rhizoma BOECKELMAN, JACOB A 1655 Final Rejection Apr 08, 2022

Managing Mthera Pharma Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month